Physician profile
John W Shaw
NPI 1104858745
$8,908.54
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,770 · 2020: $1,460 · 2021: $214 · 2022: $64.26 · 2023: $164 · 2024: $85.27 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,016.47 | 2019-2020 | |
| Organogenesis INC. | $1,213.22 | 2019-2025 | Affinity, Puraply, Apligraf |
| Davol INC. | $248.00 | 2020-2023 | Phasix Mesh |
| Smith+Nephew, INC. | $113.19 | 2024-2025 | Collagenase Santyl |
| Takeda Pharmaceuticals U.S.A., INC. | $93.69 | 2020-2022 | |
| Shire North American Group INC | $57.94 | 2019 | |
| Karl Storz Endoscopy-America | $45.00 | 2019 | |
| Hemosonics LLC | $39.34 | 2025 | Qunatra Qplus System, Quantra Qplus System |
| Aroa Biosurgery Incorporated | $23.88 | 2019 | |
| Braintree Laboratories, INC. | $17.03 | 2021 | |
| Antares Pharma, INC. | $13.95 | 2022 | |
| Integra Lifesciences Corporation | $13.61 | 2019 | |
| Travere Therapeutics, INC. | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.